Clin2
NCT06747611Possibly a fitRecruiting

Gut bacteria transplant for alopecia areata

Alopecia AreataAlopecia TotalisAlopecia Universalis

Part of Skin clinical trials.

This study tests whether transplanting healthy gut bacteria can help people with moderate to severe alopecia areata regrow hair. You will take antibiotics to prepare your gut, then receive the transplant through a colonoscopy or capsules.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
40 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have moderate to severe alopecia areata (at least 30% scalp hair loss).
  • Your hair loss has lasted at least 3 months and is not growing back on its own.
  • You are not taking any JAK inhibitors, steroids, or other hair regrowth treatments for at least 1 month before the study starts (and throughout the study).
  • You do not have active infections, serious gut conditions, or allergies to the study antibiotics (vancomycin or neomycin).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07705217Not yet recruiting
Gut bacteria transplant for alopecia areata

This study tests whether changing the bacteria in your gut (using a fecal transplant given as capsules or through a colonoscopy) can help treat alopecia areata, a condition that causes hair loss. It looks at how gut and skin bacteria are linked to your hair loss.

Opatija
NCT07533006Recruiting· Phase 2
Testing LY4005130 for severe hair loss (alopecia areata)

This study tests whether a new drug called LY4005130 can help regrow hair in adults with severe alopecia areata (an autoimmune condition causing patchy or widespread hair loss). The trial is looking for people who have lost a significant amount of hair and haven't seen it grow back on its own for at least 6 months.

Fremont, California
NCT06104839Recruiting· Phase 2
Oral NXC-736 for moderate to severe alopecia areata

This trial tests an oral medication called NXC-736 for people with moderate to severe alopecia areata. It aims to see if the drug is safe and can help regrow hair.

Seoul
NCT06012240Recruiting· Phase 3
Testing Upadacitinib for Severe Alopecia Areata

This study tests an oral tablet called upadacitinib for people with severe alopecia areata who have lost at least half of their scalp hair. It aims to see if the drug can safely help hair regrow.

Birmingham, Alabama
NCT07749716Recruiting· Phase 2
Oral tablet for severe hair loss

This study tests an experimental oral tablet for severe alopecia areata, a condition that causes patches of hair to fall out. The goal is to see if it can help regrow hair safely. You may be able to join if you have this type of hair loss and meet the health requirements.

Beijing, Beijing Municipality
NCT07205159Recruiting· Phase 1
A study of FB102 for severe alopecia areata

This trial tests a new drug called FB102 for people with severe to very severe alopecia areata, a condition that causes at least half of scalp hair to be lost. It aims to see if the drug is safe and can help hair grow back.

Saint Leonards, New South Wales (nsw)

Hear when a new Alopecia Areata trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.